Company intelligence / Profile preview

Plex Research

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Plex's platform enables identification and ranking of novel drug targets, reveals repurposing opportunities, and provides traceable experimental support for each hypothesis; widely used by major pharma and biotech clients but does not publicly disclose clinical pipeline or direct therapeutic results

Therapeutic areas: OncologyOther
Modalities: Small moleculeBiologicMonoclonal antibodyCRISPR-based therapyRNA therapyothers (platform is modality agnostic)
Industry: Drug Discovery Services

Partnerships

Ginkgo Bioworks/Ginkgo Datapoints (AI drug discovery with GDPx2 dataset)Academic institutions (Harvard Medical School, preprint collaborations)Multiple undisclosed major pharmaceutical company clients

Beyond the preview

Go deeper on Plex Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plex Research.

Explore the full profile